dr. mascarenhas on the need to develop curative therapies in myelofibrosis
Published 4 years ago • 158 plays • Length 1:38Download video MP4
Download video MP3
Similar videos
-
2:00
dr. mascarenhas on approved and emerging treatment options in myelofibrosis
-
1:37
dr. mascarenhas on the potential role of pacritinib in mpns
-
1:52
dr. john mascarenhas on the comfort-i/ii studies for ruxolitinib in myelofibrosis
-
2:16
dr. mascarenhas discusses pacritinib in myelofibrosis
-
2:47
mpn research and optimism about curative therapies
-
2:22
what are the benefits of mpn inhibitor treatment?
-
1:47
the evolution of myelofibrosis treatment and modern-day management
-
4:58
treatment of myelofibrosis: emerging therapies
-
2:45
what to expect when starting mpn inhibitor therapy
-
0:56
john mascarenhas, md, on the individualized management of myeloproliferative neoplasms
-
4:35
patient considerations that impact mpn treatment decisions
-
4:04
which tests do you need following an mpn diagnosis?
-
1:02
dr. kremyanskaya on unmet needs in myelofibrosis
-
2:18
dr. snyder on the quest to revolutionize management of myelofibrosis
-
2:59
how do mpns progress from one disease to the next?
-
4:53
what questions should patients ask about mpn test results?
-
1:14
john mascarenhas, md, on jak inhibitors & combination therapies in myeloproliferative neoplasms
-
1:14
dr. mesa on the emergence of jak inhibitors in myelofibrosis
-
1:24
dr. mesa on current data with ruxolitinib and fedratinib in myelofibrosis